140 related articles for article (PubMed ID: 1426765)
21. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.
Yoneda T; Lyall RM; Alsina MM; Persons PE; Spada AP; Levitzki A; Zilberstein A; Mundy GR
Cancer Res; 1991 Aug; 51(16):4430-5. PubMed ID: 1651159
[TBL] [Abstract][Full Text] [Related]
22. Tyrphostins and other tyrosine kinase inhibitors.
Levitzki A; Mishani E
Annu Rev Biochem; 2006; 75():93-109. PubMed ID: 16756486
[TBL] [Abstract][Full Text] [Related]
23. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro.
Gazit A; Osherov N; Gilon C; Levitzki A
J Med Chem; 1996 Dec; 39(25):4905-11. PubMed ID: 8960549
[TBL] [Abstract][Full Text] [Related]
24. Regulation of a swelling-activated chloride current in bovine endothelium by protein tyrosine phosphorylation and G proteins.
Voets T; Manolopoulos V; Eggermont J; Ellory C; Droogmans G; Nilius B
J Physiol; 1998 Jan; 506 ( Pt 2)(Pt 2):341-52. PubMed ID: 9490863
[TBL] [Abstract][Full Text] [Related]
25. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy.
Ben-Bassat H
Curr Opin Investig Drugs; 2001 Nov; 2(11):1539-45. PubMed ID: 11763154
[TBL] [Abstract][Full Text] [Related]
26. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
[TBL] [Abstract][Full Text] [Related]
27. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of tyrosine phosphorylation potentiates substrate-induced neurite growth.
Bixby JL; Jhabvala P
J Neurobiol; 1992 Jul; 23(5):468-80. PubMed ID: 1279111
[TBL] [Abstract][Full Text] [Related]
29. Induction of the differentiated phenotype in human colon cancer cell is associated with the attenuation of subcellular tyrosine phosphorylation.
Schwartz B; Lamprecht SA; Polak-Charcon S; Niv Y; Kim YS
Oncol Res; 1995; 7(6):277-87. PubMed ID: 8527862
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants.
Fishman D; Galitzki L; Priel E; Segal S
Cancer Res; 1997 Dec; 57(23):5410-5. PubMed ID: 9393768
[TBL] [Abstract][Full Text] [Related]
31. Receptor-mediated activation of human B lymphocytes in a nonphosphotyrosine-dependent manner.
Roifman CM; Wang G
J Immunol; 1992 Aug; 149(4):1179-84. PubMed ID: 1380035
[TBL] [Abstract][Full Text] [Related]
32. Clastogenic effects of two tyrosine kinase inhibitors, tyrphostin 23 and tyrphostin 46, on a transformed (CHO-K1) and on a primary embryonic chinese hamster cell line (CHE).
Bassi L; Buzzi R; Fiore M; Palitti F
Mutagenesis; 2000 Jul; 15(4):341-7. PubMed ID: 10887214
[TBL] [Abstract][Full Text] [Related]
33. Hormone induction of luteinization and prostaglandin endoperoxide synthase-2 involves multiple cellular signaling pathways.
Morris JK; Richards JS
Endocrinology; 1993 Aug; 133(2):770-9. PubMed ID: 8393774
[TBL] [Abstract][Full Text] [Related]
34. Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line.
Boyer B; Thiery JP
J Cell Biol; 1993 Feb; 120(3):767-76. PubMed ID: 7678836
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 induces protein tyrosine phosphorylation in T cells.
Muñoz E; Zubiaga A; Huang C; Huber BT
Eur J Immunol; 1992 Jun; 22(6):1391-6. PubMed ID: 1376256
[TBL] [Abstract][Full Text] [Related]
36. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
Ramdas L; McMurray JS; Budde RJ
Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
[TBL] [Abstract][Full Text] [Related]
37. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
Sauro MD; Thomas B
J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
[TBL] [Abstract][Full Text] [Related]
38. Protein-tyrosine kinases: potential targets for anticancer drug development.
Burke TR
Stem Cells; 1994 Jan; 12(1):1-6. PubMed ID: 7511455
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
[TBL] [Abstract][Full Text] [Related]
40. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
